<abstracts-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:dn="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/abstract/scopus_id/44849130357</prism:url><dc:identifier>SCOPUS_ID:44849130357</dc:identifier><eid>2-s2.0-44849130357</eid><pubmed-id>17874182</pubmed-id><prism:doi>10.1007/s10549-007-9724-3</prism:doi><dc:title>The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: An immunohistochemical study</dc:title><prism:aggregationType>Journal</prism:aggregationType><srctype>j</srctype><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><citedby-count>44</citedby-count><prism:publicationName>Breast Cancer Research and Treatment</prism:publicationName><source-id>28766</source-id><prism:issn>01676806</prism:issn><prism:volume>110</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:startingPage>317</prism:startingPage><prism:endingPage>326</prism:endingPage><prism:pageRange>317-326</prism:pageRange><prism:coverDate>2008-07-01</prism:coverDate><openaccess>0</openaccess><openaccessFlag>false</openaccessFlag><dc:creator><author seq="1" auid="7004138152"><ce:initials>R.</ce:initials><ce:indexed-name>Golouh R.</ce:indexed-name><ce:surname>Golouh</ce:surname><ce:given-name>Rastko</ce:given-name><preferred-name><ce:initials>R.</ce:initials><ce:indexed-name>Golouh R.</ce:indexed-name><ce:surname>Golouh</ce:surname><ce:given-name>Rastko</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/7004138152</author-url><affiliation id="60000966" href="https://api.elsevier.com/content/affiliation/affiliation_id/60000966"/></author></dc:creator><dc:description><abstract xmlns="" original="y" xml:lang="eng">
                        <ce:para>Introduction: We recently found that DNA methylation of S100A2, spleen tyrosine kinase (SYK), and Stathmin-1 (STMN1) correlates with response to tamoxifen therapy in metastatic breast cancer. In this retrospective study, we investigated immunohistochemically whether these three markers are predictors of relapse in early breast cancer (EBC) patients treated with adjuvant tamoxifen alone. Methods: Immunohistochemical staining was performed for S100A2, SYK and STMN1 on a tissue microarray containing ER-positive invasive breast carcinomas from a study cohort of 215 operable breast cancer patients, who underwent radical local therapy and who were treated with adjuvant tamoxifen monotherapy. Cox regression was used to correlate staining intensity of the three markers with main endpoints in our study; disease-free survival (DFS), and disease-specific survival (DSS). Results: In univariate analysis, only STMN1 staining intensity strongly correlated with DFS (P = 0.014) and DSS (P = 0.002). In the groups of low and high STMN1 intensity, DFS was 84% and 63%, and DSS was 89% and 70%. STMN1 retained its prognostic value for DFS (P = 0.002) and DSS (&lt;0.001) in the multivariate model together with lymph node status. We found also a trend to better DFS in patients with low STMN1 intensity in both lymph node-positive (P = 0.001) and -negative patients (P = 0.065). As the tumour cells did not express S100A2 (except in one case) the potential prognostic value of this marker was not evaluated. Conclusions: Staining intensity of STMN1, but not SYK, predicted outcome in our collective of ER- positive tamoxifen treated EBC patients. © 2007 Springer Science+Business Media, LLC.</ce:para>
                    </abstract></dc:description><link href="https://api.elsevier.com/content/abstract/scopus_id/44849130357" rel="self"/><link href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=44849130357&amp;origin=inward" rel="scopus"/><link href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=44849130357&amp;origin=inward" rel="scopus-citedby"/></coredata><affiliation id="60116615" href="https://api.elsevier.com/content/affiliation/affiliation_id/60116615"><affilname>Epigenomics AG</affilname><affiliation-city>Berlin</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation id="60103459" href="https://api.elsevier.com/content/affiliation/affiliation_id/60103459"><affilname>Klinikum rechts der Isar der Technischen Universität München</affilname><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation id="60032114" href="https://api.elsevier.com/content/affiliation/affiliation_id/60032114"><affilname>Erasmus University Medical Center</affilname><affiliation-city>Rotterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation id="60031106" href="https://api.elsevier.com/content/affiliation/affiliation_id/60031106"><affilname>University of Ljubljana</affilname><affiliation-city>Ljubljana</affiliation-city><affiliation-country>Slovenia</affiliation-country></affiliation><affiliation id="60007971" href="https://api.elsevier.com/content/affiliation/affiliation_id/60007971"><affilname>University of Copenhagen, Faculty of Life Sciences</affilname><affiliation-city>Copenhagen</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><affiliation id="60000966" href="https://api.elsevier.com/content/affiliation/affiliation_id/60000966"><affilname>Onkološki inštitut Ljubljana</affilname><affiliation-city>Ljubljana</affiliation-city><affiliation-country>Slovenia</affiliation-country></affiliation><authors><author seq="1" auid="7004138152"><ce:initials>R.</ce:initials><ce:indexed-name>Golouh R.</ce:indexed-name><ce:surname>Golouh</ce:surname><ce:given-name>Rastko</ce:given-name><preferred-name><ce:initials>R.</ce:initials><ce:indexed-name>Golouh R.</ce:indexed-name><ce:surname>Golouh</ce:surname><ce:given-name>Rastko</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/7004138152</author-url><affiliation id="60000966" href="https://api.elsevier.com/content/affiliation/affiliation_id/60000966"/></author><author seq="2" auid="7004393140"><ce:initials>T.</ce:initials><ce:indexed-name>Cufer T.</ce:indexed-name><ce:surname>Cufer</ce:surname><ce:given-name>Tanja</ce:given-name><preferred-name><ce:initials>T.</ce:initials><ce:indexed-name>Cufer T.</ce:indexed-name><ce:surname>Cufer</ce:surname><ce:given-name>Tanja</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/7004393140</author-url><affiliation id="60000966" href="https://api.elsevier.com/content/affiliation/affiliation_id/60000966"/></author><author seq="3" auid="55883901600"><ce:initials>A.</ce:initials><ce:indexed-name>Sadikov A.</ce:indexed-name><ce:surname>Sadikov</ce:surname><ce:given-name>Aleksander</ce:given-name><preferred-name><ce:initials>A.</ce:initials><ce:indexed-name>Sadikov A.</ce:indexed-name><ce:surname>Sadikov</ce:surname><ce:given-name>Aleksander</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/55883901600</author-url><affiliation id="60031106" href="https://api.elsevier.com/content/affiliation/affiliation_id/60031106"/></author><author seq="4" auid="57200992159"><ce:initials>P.</ce:initials><ce:indexed-name>Nussdorfer P.</ce:indexed-name><ce:surname>Nussdorfer</ce:surname><ce:given-name>Petra</ce:given-name><preferred-name><ce:initials>P.</ce:initials><ce:indexed-name>Nussdorfer P.</ce:indexed-name><ce:surname>Nussdorfer</ce:surname><ce:given-name>Petra</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/57200992159</author-url><affiliation id="60000966" href="https://api.elsevier.com/content/affiliation/affiliation_id/60000966"/></author><author seq="5" auid="7004239116"><ce:initials>P.A.</ce:initials><ce:indexed-name>Usher P.A.</ce:indexed-name><ce:surname>Usher</ce:surname><ce:given-name>Pernille Autzen</ce:given-name><preferred-name><ce:initials>P.A.</ce:initials><ce:indexed-name>Usher P.</ce:indexed-name><ce:surname>Usher</ce:surname><ce:given-name>Pernille Autzen</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/7004239116</author-url><affiliation id="60007971" href="https://api.elsevier.com/content/affiliation/affiliation_id/60007971"/></author><author seq="6" auid="55643523200"><ce:initials>N.</ce:initials><ce:indexed-name>Brunner N.</ce:indexed-name><ce:surname>Brünner</ce:surname><ce:given-name>Nils</ce:given-name><preferred-name><ce:initials>N.</ce:initials><ce:indexed-name>Brünner N.</ce:indexed-name><ce:surname>Brünner</ce:surname><ce:given-name>Nils</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/55643523200</author-url><affiliation id="60007971" href="https://api.elsevier.com/content/affiliation/affiliation_id/60007971"/></author><author seq="7" auid="7401931237"><ce:initials>M.</ce:initials><ce:indexed-name>Schmitt M.</ce:indexed-name><ce:surname>Schmitt</ce:surname><ce:given-name>Manfred</ce:given-name><preferred-name><ce:initials>M.</ce:initials><ce:indexed-name>Schmitt M.</ce:indexed-name><ce:surname>Schmitt</ce:surname><ce:given-name>Manfred</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/7401931237</author-url><affiliation id="60103459" href="https://api.elsevier.com/content/affiliation/affiliation_id/60103459"/></author><author seq="8" auid="6602823941"><ce:initials>R.</ce:initials><ce:indexed-name>Lesche R.</ce:indexed-name><ce:surname>Lesche</ce:surname><ce:given-name>Ralf</ce:given-name><preferred-name><ce:initials>R.</ce:initials><ce:indexed-name>Lesche R.</ce:indexed-name><ce:surname>Lesche</ce:surname><ce:given-name>Ralf</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/6602823941</author-url><affiliation id="60116615" href="https://api.elsevier.com/content/affiliation/affiliation_id/60116615"/></author><author seq="9" auid="36475374200"><ce:initials>S.</ce:initials><ce:indexed-name>Maier S.</ce:indexed-name><ce:surname>Maier</ce:surname><ce:given-name>Sabine</ce:given-name><preferred-name><ce:initials>S.</ce:initials><ce:indexed-name>Maier S.</ce:indexed-name><ce:surname>Maier</ce:surname><ce:given-name>Sabine</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/36475374200</author-url><affiliation id="60116615" href="https://api.elsevier.com/content/affiliation/affiliation_id/60116615"/></author><author seq="10" auid="7003736023"><ce:initials>M.</ce:initials><ce:indexed-name>Timmermans M.</ce:indexed-name><ce:surname>Timmermans</ce:surname><ce:given-name>Mieke</ce:given-name><preferred-name><ce:initials>M.</ce:initials><ce:indexed-name>Timmermans M.</ce:indexed-name><ce:surname>Timmermans</ce:surname><ce:given-name>Mieke</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/7003736023</author-url><affiliation id="60032114" href="https://api.elsevier.com/content/affiliation/affiliation_id/60032114"/></author><author seq="11" auid="7006484454"><ce:initials>J.A.</ce:initials><ce:indexed-name>Foekens J.A.</ce:indexed-name><ce:surname>Foekens</ce:surname><ce:given-name>John A.</ce:given-name><preferred-name><ce:initials>J.A.</ce:initials><ce:indexed-name>Foekens J.</ce:indexed-name><ce:surname>Foekens</ce:surname><ce:given-name>John A.</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/7006484454</author-url><affiliation id="60032114" href="https://api.elsevier.com/content/affiliation/affiliation_id/60032114"/></author><author seq="12" auid="7201836882"><ce:initials>J.W.M.</ce:initials><ce:indexed-name>Martens J.W.M.</ce:indexed-name><ce:surname>Martens</ce:surname><ce:given-name>John W. M.</ce:given-name><preferred-name><ce:initials>J.W.M.</ce:initials><ce:indexed-name>Martens J.</ce:indexed-name><ce:surname>Martens</ce:surname><ce:given-name>John W.M.</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/7201836882</author-url><affiliation id="60032114" href="https://api.elsevier.com/content/affiliation/affiliation_id/60032114"/></author></authors><language xml:lang="eng"/><authkeywords><author-keyword>ER</author-keyword><author-keyword>Immunohistochemistry</author-keyword><author-keyword>Primary breast carcinoma</author-keyword><author-keyword>S100A2</author-keyword><author-keyword>Stathmin-1</author-keyword><author-keyword>SYK</author-keyword><author-keyword>Tamoxifen</author-keyword></authkeywords><idxterms/><subject-areas><subject-area code="2730" abbrev="MEDI">Oncology</subject-area><subject-area code="1306" abbrev="BIOC">Cancer Research</subject-area></subject-areas><item xmlns=""><xocs:meta><xocs:funding-list has-funding-info="1" pui-match="primary"><xocs:funding-addon-generated-timestamp>2019-03-20T22:40:49.221Z</xocs:funding-addon-generated-timestamp><xocs:funding-addon-type>http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/nlp</xocs:funding-addon-type><xocs:funding><xocs:funding-agency-matched-string>European Union Sixth Framework Programme</xocs:funding-agency-matched-string><xocs:funding-id>LSHC-CT-2003–504586</xocs:funding-id><xocs:funding-agency>Sixth Framework Programme</xocs:funding-agency><xocs:funding-agency-id>http://data.elsevier.com/vocabulary/SciValFunders/501100004965</xocs:funding-agency-id><xocs:funding-agency-country>http://sws.geonames.org/6695072/</xocs:funding-agency-country></xocs:funding><xocs:funding-text>Acknowledgments This research was supported by the European Union Sixth Framework Programme (LSHC-CT-2003–504586). Conflict of interest statement:Ralf Lesche and Sabine Maier are employees and/or stockholders of Epigenomics AG (Berlin, Germany), a company that aims to commercialize DNA methylation markers, including S100A2, STMN1 and SYK. John Martens, Nadia Harbeck, Manfred Schmitt, Sabine Maier, and John Foekens are inventors of a patent on these DNA methylation markers (WO 2004 035803). This patent has been filed by Epigenomics AG.</xocs:funding-text></xocs:funding-list></xocs:meta><ait:process-info><ait:date-delivered day="17" month="04" timestamp="2019-04-17T01:28:37.000037-04:00" year="2019"/><ait:date-sort day="01" month="07" year="2008"/><ait:status stage="S300" state="update" type="core"/></ait:process-info><bibrecord><item-info><copyright type="Elsevier">Copyright 2009 Elsevier B.V., All rights reserved.</copyright><copyright type="Medline Descriptors">MEDLINE® is the source for the MeSH terms of this document.</copyright><itemidlist>
                    <ce:doi>10.1007/s10549-007-9724-3</ce:doi>
                    <itemid idtype="PUI">351793880</itemid>
                    <itemid idtype="EMBASE">2008275073</itemid>
                    <itemid idtype="CABS">2008157610</itemid>
                    <itemid idtype="MEDL">17874182</itemid>
                    <itemid idtype="SCP">44849130357</itemid>
                    <itemid idtype="SGR">44849130357</itemid>
                </itemidlist><history>
                    <date-created day="12" month="06" year="2008"/>
                </history><dbcollection>EMBASE</dbcollection><dbcollection>CABS</dbcollection><dbcollection>MEDL</dbcollection><dbcollection>Scopusbase</dbcollection></item-info><head><citation-info><citation-type code="ar"/><citation-language xml:lang="eng" language="English"/><abstract-language xml:lang="eng" language="English"/><author-keywords>
                        <author-keyword xml:lang="eng">ER</author-keyword>
                        <author-keyword xml:lang="eng">Immunohistochemistry</author-keyword>
                        <author-keyword xml:lang="eng">Primary breast carcinoma</author-keyword>
                        <author-keyword xml:lang="eng">S100A2</author-keyword>
                        <author-keyword xml:lang="eng">Stathmin-1</author-keyword>
                        <author-keyword xml:lang="eng">SYK</author-keyword>
                        <author-keyword xml:lang="eng">Tamoxifen</author-keyword>
                    </author-keywords></citation-info><citation-title><titletext original="y" xml:lang="eng" language="English">The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: An immunohistochemical study</titletext></citation-title><author-group><author auid="7004138152" seq="1"><ce:initials>R.</ce:initials><ce:indexed-name>Golouh R.</ce:indexed-name><ce:surname>Golouh</ce:surname><ce:given-name>Rastko</ce:given-name><preferred-name>
                            <ce:initials>R.</ce:initials>
                            <ce:indexed-name>Golouh R.</ce:indexed-name>
                            <ce:surname>Golouh</ce:surname>
                            <ce:given-name>Rastko</ce:given-name>
                        </preferred-name></author><author auid="7004393140" seq="2"><ce:initials>T.</ce:initials><ce:indexed-name>Cufer T.</ce:indexed-name><ce:surname>Cufer</ce:surname><ce:given-name>Tanja</ce:given-name><preferred-name>
                            <ce:initials>T.</ce:initials>
                            <ce:indexed-name>Cufer T.</ce:indexed-name>
                            <ce:surname>Cufer</ce:surname>
                            <ce:given-name>Tanja</ce:given-name>
                        </preferred-name></author><author auid="57200992159" seq="4"><ce:initials>P.</ce:initials><ce:indexed-name>Nussdorfer P.</ce:indexed-name><ce:surname>Nussdorfer</ce:surname><ce:given-name>Petra</ce:given-name><preferred-name>
                            <ce:initials>P.</ce:initials>
                            <ce:indexed-name>Nussdorfer P.</ce:indexed-name>
                            <ce:surname>Nussdorfer</ce:surname>
                            <ce:given-name>Petra</ce:given-name>
                        </preferred-name></author><affiliation afid="60000966" country="svn"><organization>Institute of Oncology</organization><address-part>Zaloška 2</address-part><city-group>Ljubljana 1000</city-group><affiliation-id afid="60000966"/><country>Slovenia</country></affiliation></author-group><author-group><author auid="55883901600" seq="3"><ce:initials>A.</ce:initials><ce:indexed-name>Sadikov A.</ce:indexed-name><ce:surname>Sadikov</ce:surname><ce:given-name>Aleksander</ce:given-name><preferred-name>
                            <ce:initials>A.</ce:initials>
                            <ce:indexed-name>Sadikov A.</ce:indexed-name>
                            <ce:surname>Sadikov</ce:surname>
                            <ce:given-name>Aleksander</ce:given-name>
                        </preferred-name></author><affiliation afid="60031106" country="svn" dptid="104580932"><organization>Artificial Intelligence Laboratory</organization><organization>University of Ljubljana</organization><city-group>Ljubljana</city-group><affiliation-id afid="60031106" dptid="104580932"/><country>Slovenia</country></affiliation></author-group><author-group><author auid="7004239116" seq="5"><ce:initials>P.A.</ce:initials><ce:indexed-name>Usher P.A.</ce:indexed-name><ce:surname>Usher</ce:surname><ce:given-name>Pernille Autzen</ce:given-name><preferred-name>
                            <ce:initials>P.A.</ce:initials>
                            <ce:indexed-name>Usher P.</ce:indexed-name>
                            <ce:surname>Usher</ce:surname>
                            <ce:given-name>Pernille Autzen</ce:given-name>
                        </preferred-name></author><author auid="55643523200" seq="6"><ce:initials>N.</ce:initials><ce:indexed-name>Brunner N.</ce:indexed-name><ce:surname>Brünner</ce:surname><ce:given-name>Nils</ce:given-name><preferred-name>
                            <ce:initials>N.</ce:initials>
                            <ce:indexed-name>Brünner N.</ce:indexed-name>
                            <ce:surname>Brünner</ce:surname>
                            <ce:given-name>Nils</ce:given-name>
                        </preferred-name></author><affiliation afid="60007971" country="dnk" dptid="106825096"><organization>Royal Veterinary and Agriculture University</organization><city-group>Frederiksberg</city-group><affiliation-id afid="60007971" dptid="106825096"/><country>Denmark</country></affiliation></author-group><author-group><author auid="7401931237" seq="7"><ce:initials>M.</ce:initials><ce:indexed-name>Schmitt M.</ce:indexed-name><ce:surname>Schmitt</ce:surname><ce:given-name>Manfred</ce:given-name><preferred-name>
                            <ce:initials>M.</ce:initials>
                            <ce:indexed-name>Schmitt M.</ce:indexed-name>
                            <ce:surname>Schmitt</ce:surname>
                            <ce:given-name>Manfred</ce:given-name>
                        </preferred-name></author><affiliation afid="60103459" country="deu" dptid="120271110"><organization>Department of Obstetrics and Gynaecology</organization><organization>Klinikum Rechts der Isar</organization><organization>Technical University of Munich</organization><city-group>Munich</city-group><affiliation-id afid="60103459" dptid="120271110"/><affiliation-id afid="60019722"/><country>Germany</country></affiliation></author-group><author-group><author auid="6602823941" seq="8"><ce:initials>R.</ce:initials><ce:indexed-name>Lesche R.</ce:indexed-name><ce:surname>Lesche</ce:surname><ce:given-name>Ralf</ce:given-name><preferred-name>
                            <ce:initials>R.</ce:initials>
                            <ce:indexed-name>Lesche R.</ce:indexed-name>
                            <ce:surname>Lesche</ce:surname>
                            <ce:given-name>Ralf</ce:given-name>
                        </preferred-name></author><author auid="36475374200" seq="9"><ce:initials>S.</ce:initials><ce:indexed-name>Maier S.</ce:indexed-name><ce:surname>Maier</ce:surname><ce:given-name>Sabine</ce:given-name><preferred-name>
                            <ce:initials>S.</ce:initials>
                            <ce:indexed-name>Maier S.</ce:indexed-name>
                            <ce:surname>Maier</ce:surname>
                            <ce:given-name>Sabine</ce:given-name>
                        </preferred-name></author><affiliation afid="60116615" country="deu"><organization>Epigenomics AG</organization><city-group>Berlin</city-group><affiliation-id afid="60116615"/><country>Germany</country></affiliation></author-group><author-group><author auid="7003736023" seq="10"><ce:initials>M.</ce:initials><ce:indexed-name>Timmermans M.</ce:indexed-name><ce:surname>Timmermans</ce:surname><ce:given-name>Mieke</ce:given-name><preferred-name>
                            <ce:initials>M.</ce:initials>
                            <ce:indexed-name>Timmermans M.</ce:indexed-name>
                            <ce:surname>Timmermans</ce:surname>
                            <ce:given-name>Mieke</ce:given-name>
                        </preferred-name></author><author auid="7006484454" date-locked="2017-11-09T19:38:55.004" seq="11"><ce:initials>J.A.</ce:initials><ce:indexed-name>Foekens J.A.</ce:indexed-name><ce:surname>Foekens</ce:surname><ce:given-name>John A.</ce:given-name><preferred-name>
                            <ce:initials>J.A.</ce:initials>
                            <ce:indexed-name>Foekens J.</ce:indexed-name>
                            <ce:surname>Foekens</ce:surname>
                            <ce:given-name>John A.</ce:given-name>
                        </preferred-name></author><author auid="7201836882" seq="12"><ce:initials>J.W.M.</ce:initials><ce:indexed-name>Martens J.W.M.</ce:indexed-name><ce:surname>Martens</ce:surname><ce:given-name>John W. M.</ce:given-name><preferred-name>
                            <ce:initials>J.W.M.</ce:initials>
                            <ce:indexed-name>Martens J.</ce:indexed-name>
                            <ce:surname>Martens</ce:surname>
                            <ce:given-name>John W.M.</ce:given-name>
                        </preferred-name></author><affiliation afid="60032114" country="nld" dptid="104631593"><organization>Department of Medical Oncology</organization><organization>Erasmus MC</organization><city-group>Rotterdam</city-group><affiliation-id afid="60032114" dptid="104631593"/><country>Netherlands</country></affiliation></author-group><correspondence><person>
                        <ce:initials>T.</ce:initials>
                        <ce:indexed-name>Cufer T.</ce:indexed-name>
                        <ce:surname>Cufer</ce:surname>
                    </person><affiliation country="svn"><organization>Institute of Oncology</organization><address-part>Zaloška 2</address-part><city-group>Ljubljana 1000</city-group><country>Slovenia</country></affiliation></correspondence><abstracts><abstract original="y" xml:lang="eng">
                        <ce:para>Introduction: We recently found that DNA methylation of S100A2, spleen tyrosine kinase (SYK), and Stathmin-1 (STMN1) correlates with response to tamoxifen therapy in metastatic breast cancer. In this retrospective study, we investigated immunohistochemically whether these three markers are predictors of relapse in early breast cancer (EBC) patients treated with adjuvant tamoxifen alone. Methods: Immunohistochemical staining was performed for S100A2, SYK and STMN1 on a tissue microarray containing ER-positive invasive breast carcinomas from a study cohort of 215 operable breast cancer patients, who underwent radical local therapy and who were treated with adjuvant tamoxifen monotherapy. Cox regression was used to correlate staining intensity of the three markers with main endpoints in our study; disease-free survival (DFS), and disease-specific survival (DSS). Results: In univariate analysis, only STMN1 staining intensity strongly correlated with DFS (P = 0.014) and DSS (P = 0.002). In the groups of low and high STMN1 intensity, DFS was 84% and 63%, and DSS was 89% and 70%. STMN1 retained its prognostic value for DFS (P = 0.002) and DSS (&lt;0.001) in the multivariate model together with lymph node status. We found also a trend to better DFS in patients with low STMN1 intensity in both lymph node-positive (P = 0.001) and -negative patients (P = 0.065). As the tumour cells did not express S100A2 (except in one case) the potential prognostic value of this marker was not evaluated. Conclusions: Staining intensity of STMN1, but not SYK, predicted outcome in our collective of ER- positive tamoxifen treated EBC patients. © 2007 Springer Science+Business Media, LLC.</ce:para>
                    </abstract></abstracts><source country="usa" srcid="28766" type="j"><sourcetitle>Breast Cancer Research and Treatment</sourcetitle><sourcetitle-abbrev>Breast Cancer Res. Treat.</sourcetitle-abbrev><issn type="print">01676806</issn><codencode>BCTRD</codencode><volisspag>
                        <voliss issue="2" volume="110"/>
                        <pagerange first="317" last="326"/>
                    </volisspag><publicationyear first="2008"/><publicationdate>
                        <year>2008</year>
                        <month>07</month>
                    <date-text xfab-added="true">July 2008</date-text></publicationdate></source><enhancement><classificationgroup><classifications type="CABSCLASS">
                            <classification>
                                 
                                <classification-code>87.3.2</classification-code>
                                 
                                <classification-description>CANCER RESEARCH; DIAGNOSIS AND PROGNOSIS; Molecular and Cellular Techniques</classification-description>
                                 
                            </classification>
                            <classification>
                                 
                                <classification-code>87.4.1.3</classification-code>
                                 
                                <classification-description>CANCER RESEARCH; TREATMENT; Chemotherapy; Endocrine therapy</classification-description>
                                 
                            </classification>
                            <classification>
                                 
                                <classification-code>87.5.11</classification-code>
                                 
                                <classification-description>CANCER RESEARCH; CLINICAL INVESTIGATIONS BY ORGAN SITE; Breast</classification-description>
                                 
                            </classification>
                        </classifications><classifications type="EMCLASS">
                            <classification>
                                 
                                <classification-code>5.4.11</classification-code>
                                 
                                <classification-description>General Pathology and Pathological Anatomy; ORGAN PATHOLOGY; Breast</classification-description>
                                 
                            </classification>
                            <classification>
                                 
                                <classification-code>5.3.6</classification-code>
                                 
                                <classification-description>General Pathology and Pathological Anatomy; GENERAL PATHOLOGY; Cancer pathology</classification-description>
                                 
                            </classification>
                            <classification>
                                 
                                <classification-code>5.3.1</classification-code>
                                 
                                <classification-description>General Pathology and Pathological Anatomy; GENERAL PATHOLOGY; Molecular and cellular pathology</classification-description>
                                 
                            </classification>
                            <classification>
                                 
                                <classification-code>37</classification-code>
                                 
                                <classification-description>Drug Literature Index</classification-description>
                                 
                            </classification>
                            <classification>
                                 
                                <classification-code>16.4.1</classification-code>
                                 
                                <classification-description>Cancer; TREATMENT AND PATIENT MANAGEMENT; Chemotherapy</classification-description>
                                 
                            </classification>
                            <classification>
                                 
                                <classification-code>16.2.4</classification-code>
                                 
                                <classification-description>Cancer; CANCER RESEARCH; Genetics and oncogenes</classification-description>
                                 
                            </classification>
                            <classification>
                                 
                                <classification-code>16.19</classification-code>
                                 
                                <classification-description>Cancer; BREAST</classification-description>
                                 
                            </classification>
                        </classifications><classifications type="ASJC">
                            <classification>2730</classification>
                            <classification>1306</classification>
                        </classifications><classifications type="SUBJABBR"><classification>MEDI</classification><classification>BIOC</classification></classifications></classificationgroup><chemicalgroup>
                        <chemicals source="esbd">
                            <chemical>
                                <chemical-name>protein kinase Syk</chemical-name>
                                <cas-registry-number>138674-26-7</cas-registry-number>
                            </chemical>
                            <chemical>
                                <chemical-name>tamoxifen</chemical-name>
                                <cas-registry-number>10540-29-1</cas-registry-number>
                            </chemical>
                        </chemicals>
                        <chemicals source="nlm">
                            <chemical>
                                <chemical-name>Chemotactic Factors</chemical-name>
                                <cas-registry-number>0</cas-registry-number>
                            </chemical>
                            <chemical>
                                <chemical-name>Intracellular Signaling Peptides and Proteins</chemical-name>
                                <cas-registry-number>0</cas-registry-number>
                            </chemical>
                            <chemical>
                                <chemical-name>Protein-Tyrosine Kinases</chemical-name>
                                <cas-registry-number>2.7.1.112</cas-registry-number>
                            </chemical>
                            <chemical>
                                <chemical-name>Receptors, Estrogen</chemical-name>
                                <cas-registry-number>0</cas-registry-number>
                            </chemical>
                            <chemical>
                                <chemical-name>S100 Proteins</chemical-name>
                                <cas-registry-number>0</cas-registry-number>
                            </chemical>
                            <chemical>
                                <chemical-name>S100A2 protein, human</chemical-name>
                                <cas-registry-number>0</cas-registry-number>
                            </chemical>
                            <chemical>
                                <chemical-name>STMN1 protein, human</chemical-name>
                                <cas-registry-number>0</cas-registry-number>
                            </chemical>
                            <chemical>
                                <chemical-name>Stathmin</chemical-name>
                                <cas-registry-number>0</cas-registry-number>
                            </chemical>
                            <chemical>
                                <chemical-name>Syk kinase</chemical-name>
                                <cas-registry-number>2.7.1.112</cas-registry-number>
                            </chemical>
                            <chemical>
                                <chemical-name>Tamoxifen</chemical-name>
                                <cas-registry-number>10540-29-1</cas-registry-number>
                            </chemical>
                        </chemicals>
                    </chemicalgroup></enhancement></head><tail><bibliography refcount="22">
                    <reference id="1">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomized trials</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">19344364880</itemid>
                            </refd-itemidlist>
                            <ref-sourcetitle>Lancet</ref-sourcetitle>
                            <ref-publicationyear first="2005"/>
                            <ref-volisspag>
                                <voliss volume="365"/>
                                <pagerange first="1687" last="1716"/>
                            </ref-volisspag>
                            <ref-text>Early Breast Cancer Trialists' Collaborative Group (EBCTCG)</ref-text>
                        </ref-info>
                        <ref-fulltext>Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 365:1687-1716</ref-fulltext>
                    </reference>
                    <reference id="2">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>Epigenetics in human disease and prospects for epigenetic therapy</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">2642531973</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>G.</ce:initials>
                                    <ce:indexed-name>Egger G.</ce:indexed-name>
                                    <ce:surname>Egger</ce:surname>
                                </author>
                                <author seq="2">
                                    <ce:initials>G.</ce:initials>
                                    <ce:indexed-name>Liang G.</ce:indexed-name>
                                    <ce:surname>Liang</ce:surname>
                                </author>
                                <author seq="3">
                                    <ce:initials>A.</ce:initials>
                                    <ce:indexed-name>Aparicio A.</ce:indexed-name>
                                    <ce:surname>Aparicio</ce:surname>
                                </author>
                                <author seq="4">
                                    <ce:initials>P.A.</ce:initials>
                                    <ce:indexed-name>Jones P.A.</ce:indexed-name>
                                    <ce:surname>Jones</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>Nature</ref-sourcetitle>
                            <ref-publicationyear first="2004"/>
                            <ref-volisspag>
                                <voliss volume="429"/>
                                <pagerange first="457" last="463"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>Egger G, Liang G, Aparicio A, Jones PA (2004). Epigenetics in human disease and prospects for epigenetic therapy. Nature 429:457-463</ref-fulltext>
                    </reference>
                    <reference id="3">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>DNA methylation and cancer therapy: New developments and expectations</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">13144251125</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>M.</ce:initials>
                                    <ce:indexed-name>Esteller M.</ce:indexed-name>
                                    <ce:surname>Esteller</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>Curr Opin Oncol</ref-sourcetitle>
                            <ref-publicationyear first="2005"/>
                            <ref-volisspag>
                                <voliss volume="17"/>
                                <pagerange first="55" last="60"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>Esteller M (2005). DNA methylation and cancer therapy: new developments and expectations. Curr Opin Oncol 17:55-60</ref-fulltext>
                    </reference>
                    <reference id="4">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>Epigenetic gene silencing in cancer - A mechanism for early oncogenic pathway addiction</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">33644846509</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>S.B.</ce:initials>
                                    <ce:indexed-name>Baylin S.B.</ce:indexed-name>
                                    <ce:surname>Baylin</ce:surname>
                                </author>
                                <author seq="2">
                                    <ce:initials>J.E.</ce:initials>
                                    <ce:indexed-name>Ohm J.E.</ce:indexed-name>
                                    <ce:surname>Ohm</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>Nat Rev Cancer</ref-sourcetitle>
                            <ref-publicationyear first="2006"/>
                            <ref-volisspag>
                                <voliss volume="6"/>
                                <pagerange first="107" last="116"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>Baylin SB, Ohm JE (2006). Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction. Nat Rev Cancer 6:107-116</ref-fulltext>
                    </reference>
                    <reference id="5">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">20144365156</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>J.W.M.</ce:initials>
                                    <ce:indexed-name>Martens J.W.M.</ce:indexed-name>
                                    <ce:surname>Martens</ce:surname>
                                </author>
                                <author seq="2">
                                    <ce:initials>I.</ce:initials>
                                    <ce:indexed-name>Nimmrich I.</ce:indexed-name>
                                    <ce:surname>Nimmrich</ce:surname>
                                </author>
                                <author seq="3">
                                    <ce:initials>T.</ce:initials>
                                    <ce:indexed-name>Koenig T.</ce:indexed-name>
                                    <ce:surname>Koenig</ce:surname>
                                </author>
                                <author seq="4">
                                    <ce:initials>M.P.</ce:initials>
                                    <ce:indexed-name>Look M.P.</ce:indexed-name>
                                    <ce:surname>Look</ce:surname>
                                </author>
                                <author seq="5">
                                    <ce:initials>N.</ce:initials>
                                    <ce:indexed-name>Harbeck N.</ce:indexed-name>
                                    <ce:surname>Harbeck</ce:surname>
                                </author>
                                <author seq="6">
                                    <ce:initials>F.</ce:initials>
                                    <ce:indexed-name>Model F.</ce:indexed-name>
                                    <ce:surname>Model</ce:surname>
                                </author>
                                <author seq="7">
                                    <ce:initials>A.</ce:initials>
                                    <ce:indexed-name>Kluth A.</ce:indexed-name>
                                    <ce:surname>Kluth</ce:surname>
                                </author>
                                <author seq="8">
                                    <ce:initials>J.</ce:initials>
                                    <ce:indexed-name>Bolt-De Vries J.</ce:indexed-name>
                                    <ce:surname>Bolt-De Vries</ce:surname>
                                </author>
                                <author seq="9">
                                    <ce:initials>A.M.</ce:initials>
                                    <ce:indexed-name>Sieuwerts A.M.</ce:indexed-name>
                                    <ce:surname>Sieuwerts</ce:surname>
                                </author>
                                <author seq="10">
                                    <ce:initials>H.</ce:initials>
                                    <ce:indexed-name>Portengen H.</ce:indexed-name>
                                    <ce:surname>Portengen</ce:surname>
                                </author>
                                <author seq="11">
                                    <ce:initials>M.E.</ce:initials>
                                    <ce:indexed-name>Meijer-Van Gelder M.E.</ce:indexed-name>
                                    <ce:surname>Meijer-Van Gelder</ce:surname>
                                </author>
                                <author seq="12">
                                    <ce:initials>C.</ce:initials>
                                    <ce:indexed-name>Piepenbrock C.</ce:indexed-name>
                                    <ce:surname>Piepenbrock</ce:surname>
                                </author>
                                <author seq="13">
                                    <ce:initials>A.</ce:initials>
                                    <ce:indexed-name>Olek A.</ce:indexed-name>
                                    <ce:surname>Olek</ce:surname>
                                </author>
                                <author seq="14">
                                    <ce:initials>H.</ce:initials>
                                    <ce:indexed-name>Hofler H.</ce:indexed-name>
                                    <ce:surname>Höfler</ce:surname>
                                </author>
                                <author seq="15">
                                    <ce:initials>M.</ce:initials>
                                    <ce:indexed-name>Kiechle M.</ce:indexed-name>
                                    <ce:surname>Kiechle</ce:surname>
                                </author>
                                <author seq="16">
                                    <ce:initials>J.G.M.</ce:initials>
                                    <ce:indexed-name>Klijn J.G.M.</ce:indexed-name>
                                    <ce:surname>Klijn</ce:surname>
                                </author>
                                <author seq="17">
                                    <ce:initials>M.</ce:initials>
                                    <ce:indexed-name>Schmitt M.</ce:indexed-name>
                                    <ce:surname>Schmitt</ce:surname>
                                </author>
                                <author seq="18">
                                    <ce:initials>S.</ce:initials>
                                    <ce:indexed-name>Maier S.</ce:indexed-name>
                                    <ce:surname>Maier</ce:surname>
                                </author>
                                <author seq="19">
                                    <ce:initials>J.A.</ce:initials>
                                    <ce:indexed-name>Foekens J.A.</ce:indexed-name>
                                    <ce:surname>Foekens</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>Cancer Res</ref-sourcetitle>
                            <ref-publicationyear first="2005"/>
                            <ref-volisspag>
                                <voliss volume="65"/>
                                <pagerange first="4101" last="4107"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>Martens JWM, Nimmrich I, Koenig T, Look MP, Harbeck N, Model F, Kluth A, Bolt-de Vries J, Sieuwerts AM, Portengen H, Meijer-van Gelder ME, Piepenbrock C, Olek A, Höfler H, Kiechle M, Klijn JGM, Schmitt M, Maier S, Foekens JA (2005). Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer. Cancer Res 65:4101-4107</ref-fulltext>
                    </reference>
                    <reference id="6">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>DNA methylation reliably predicts risk of recurrence in tamoxifen-treated, node-negative breast cancer patients</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">44849132676</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>S.</ce:initials>
                                    <ce:indexed-name>Maier S.</ce:indexed-name>
                                    <ce:surname>Maier</ce:surname>
                                </author>
                                <author seq="2">
                                    <ce:initials>I.</ce:initials>
                                    <ce:indexed-name>Nimmrich I.</ce:indexed-name>
                                    <ce:surname>Nimmrich</ce:surname>
                                </author>
                                <author seq="3">
                                    <ce:initials>T.H.</ce:initials>
                                    <ce:indexed-name>Koenig T.H.</ce:indexed-name>
                                    <ce:surname>Koenig</ce:surname>
                                </author>
                                <author seq="4">
                                    <ce:initials>S.</ce:initials>
                                    <ce:indexed-name>Eppenberger-Castori S.</ce:indexed-name>
                                    <ce:surname>Eppenberger-Castori</ce:surname>
                                </author>
                                <author seq="5">
                                    <ce:initials>I.</ce:initials>
                                    <ce:indexed-name>Bohlmann I.</ce:indexed-name>
                                    <ce:surname>Bohlmann</ce:surname>
                                </author>
                                <author seq="6">
                                    <ce:initials>A.</ce:initials>
                                    <ce:indexed-name>Paradiso A.</ce:indexed-name>
                                    <ce:surname>Paradiso</ce:surname>
                                </author>
                                <author seq="7">
                                    <ce:initials>F.</ce:initials>
                                    <ce:indexed-name>Spyratos F.</ce:indexed-name>
                                    <ce:surname>Spyratos</ce:surname>
                                </author>
                                <author seq="8">
                                    <ce:initials>F.</ce:initials>
                                    <ce:indexed-name>Janicke F.</ce:indexed-name>
                                    <ce:surname>Jänicke</ce:surname>
                                </author>
                                <author seq="9">
                                    <ce:initials>V.</ce:initials>
                                    <ce:indexed-name>Muller V.</ce:indexed-name>
                                    <ce:surname>Müller</ce:surname>
                                </author>
                                <author seq="10">
                                    <ce:initials>Ch.</ce:initials>
                                    <ce:indexed-name>Thomssen Ch.</ce:indexed-name>
                                    <ce:surname>Thomssen</ce:surname>
                                </author>
                                <author seq="11">
                                    <ce:initials>H.</ce:initials>
                                    <ce:indexed-name>Hofler H.</ce:indexed-name>
                                    <ce:surname>Höfler</ce:surname>
                                </author>
                                <author seq="12">
                                    <ce:initials>J.</ce:initials>
                                    <ce:indexed-name>Nahrig J.</ce:indexed-name>
                                    <ce:surname>Nährig</ce:surname>
                                </author>
                                <author seq="13">
                                    <ce:initials>U.</ce:initials>
                                    <ce:indexed-name>Eppenberger U.</ce:indexed-name>
                                    <ce:surname>Eppenberger</ce:surname>
                                </author>
                                <author seq="14">
                                    <ce:initials>F.</ce:initials>
                                    <ce:indexed-name>Model F.</ce:indexed-name>
                                    <ce:surname>Model</ce:surname>
                                </author>
                                <author seq="15">
                                    <ce:initials>J.W.M.</ce:initials>
                                    <ce:indexed-name>Martens J.W.M.</ce:indexed-name>
                                    <ce:surname>Martens</ce:surname>
                                </author>
                                <author seq="16">
                                    <ce:initials>J.A.</ce:initials>
                                    <ce:indexed-name>Foekens J.A.</ce:indexed-name>
                                    <ce:surname>Foekens</ce:surname>
                                </author>
                                <author seq="17">
                                    <ce:initials>R.</ce:initials>
                                    <ce:indexed-name>Lesche R.</ce:indexed-name>
                                    <ce:surname>Lesche</ce:surname>
                                </author>
                                <author seq="18">
                                    <ce:initials>I.</ce:initials>
                                    <ce:indexed-name>Schwope I.</ce:indexed-name>
                                    <ce:surname>Schwope</ce:surname>
                                </author>
                                <author seq="19">
                                    <ce:initials>A.</ce:initials>
                                    <ce:indexed-name>Kluth A.</ce:indexed-name>
                                    <ce:surname>Kluth</ce:surname>
                                </author>
                                <author seq="20">
                                    <ce:initials>A.</ce:initials>
                                    <ce:indexed-name>Marx A.</ce:indexed-name>
                                    <ce:surname>Marx</ce:surname>
                                </author>
                                <author seq="21">
                                    <ce:initials>M.</ce:initials>
                                    <ce:indexed-name>Schmitt M.</ce:indexed-name>
                                    <ce:surname>Schmitt</ce:surname>
                                </author>
                                <author seq="22">
                                    <ce:initials>N.</ce:initials>
                                    <ce:indexed-name>Harbeck N.</ce:indexed-name>
                                    <ce:surname>Harbeck</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>Eur J Cancer</ref-sourcetitle>
                            <ref-text>(Submitted)</ref-text>
                        </ref-info>
                        <ref-fulltext>Maier S, Nimmrich I, Koenig TH, Eppenberger-Castori S, Bohlmann I, Paradiso A, Spyratos F, Jänicke F, Müller V, Thomssen Ch, Höfler H, Nährig J, Eppenberger U, Model F, Martens JWM, Foekens JA, Lesche R, Schwope I, Kluth A, Marx A, Schmitt M, Harbeck N. DNA methylation reliably predicts risk of recurrence in tamoxifen-treated, node-negative breast cancer patients. Eur J Cancer. (Submitted)</ref-fulltext>
                    </reference>
                    <reference id="7">
                        <ref-info>
                            <refd-itemidlist>
                                <itemid idtype="SGR">44849130168</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>I.</ce:initials>
                                    <ce:indexed-name>Nimmrich I.</ce:indexed-name>
                                    <ce:surname>Nimmrich</ce:surname>
                                </author>
                                <author seq="2">
                                    <ce:initials>S.</ce:initials>
                                    <ce:indexed-name>Maier S.</ce:indexed-name>
                                    <ce:surname>Maier</ce:surname>
                                </author>
                                <author seq="3">
                                    <ce:initials>M.E.</ce:initials>
                                    <ce:indexed-name>Meijer-Van Gelder M.E.</ce:indexed-name>
                                    <ce:surname>Meijer-Van Gelder</ce:surname>
                                </author>
                                <author seq="4">
                                    <ce:initials>M.P.</ce:initials>
                                    <ce:indexed-name>Look M.P.</ce:indexed-name>
                                    <ce:surname>Look</ce:surname>
                                </author>
                                <author seq="5">
                                    <ce:initials>N.</ce:initials>
                                    <ce:indexed-name>Harbeck N.</ce:indexed-name>
                                    <ce:surname>Harbeck</ce:surname>
                                </author>
                                <author seq="6">
                                    <ce:initials>I.</ce:initials>
                                    <ce:indexed-name>Schwope I.</ce:indexed-name>
                                    <ce:surname>Schwope</ce:surname>
                                </author>
                                <author seq="7">
                                    <ce:initials>Th.</ce:initials>
                                    <ce:indexed-name>Koenig Th.</ce:indexed-name>
                                    <ce:surname>Koenig</ce:surname>
                                </author>
                                <author seq="8">
                                    <ce:initials>O.</ce:initials>
                                    <ce:indexed-name>Hartmann O.</ce:indexed-name>
                                    <ce:surname>Hartmann</ce:surname>
                                </author>
                                <author seq="9">
                                    <ce:initials>A.</ce:initials>
                                    <ce:indexed-name>Kluth A.</ce:indexed-name>
                                    <ce:surname>Kluth</ce:surname>
                                </author>
                                <author seq="10">
                                    <ce:initials>F.</ce:initials>
                                    <ce:indexed-name>Model F.</ce:indexed-name>
                                    <ce:surname>Model</ce:surname>
                                </author>
                                <author seq="11">
                                    <ce:initials>J.</ce:initials>
                                    <ce:indexed-name>Bolt-De Vries J.</ce:indexed-name>
                                    <ce:surname>Bolt-De Vries</ce:surname>
                                </author>
                                <author seq="12">
                                    <ce:initials>A.M.</ce:initials>
                                    <ce:indexed-name>Sieuwerts A.M.</ce:indexed-name>
                                    <ce:surname>Sieuwerts</ce:surname>
                                </author>
                                <author seq="13">
                                    <ce:initials>H.</ce:initials>
                                    <ce:indexed-name>Portengen H.</ce:indexed-name>
                                    <ce:surname>Portengen</ce:surname>
                                </author>
                                <author seq="14">
                                    <ce:initials>J.G.M.</ce:initials>
                                    <ce:indexed-name>Klijn J.G.M.</ce:indexed-name>
                                    <ce:surname>Klijn</ce:surname>
                                </author>
                                <author seq="15">
                                    <ce:initials>M.</ce:initials>
                                    <ce:indexed-name>Schmitt M.</ce:indexed-name>
                                    <ce:surname>Schmitt</ce:surname>
                                </author>
                                <author seq="16">
                                    <ce:initials>J.A.</ce:initials>
                                    <ce:indexed-name>Foekens J.A.</ce:indexed-name>
                                    <ce:surname>Foekens</ce:surname>
                                </author>
                                <author seq="17">
                                    <ce:initials>M.J.W.</ce:initials>
                                    <ce:indexed-name>Martens M.J.W.</ce:indexed-name>
                                    <ce:surname>Martens</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>DNA Hypermethylation of PITX2 Is a Strong Marker of Poor Prognosis in Lymph Node-negative Hormone Receptor-positive Breast Cancer Patients</ref-sourcetitle>
                            <ref-text>(In preparation)</ref-text>
                        </ref-info>
                        <ref-fulltext>Nimmrich I, Maier S, Meijer-Van Gelder ME, Look MP, Harbeck N, Schwope I, Koenig Th, Hartmann O, Kluth A, Model F, Bolt-de Vries J, Sieuwerts AM, Portengen H, Klijn JGM, Schmitt M, Foekens JA, and John W. M. Martens. DNA hypermethylation of PITX2 is a strong marker of poor prognosis in lymph node-negative hormone receptor-positive breast cancer patients. (In preparation)</ref-fulltext>
                    </reference>
                    <reference id="8">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">2542629617</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>M.</ce:initials>
                                    <ce:indexed-name>Widschwendter M.</ce:indexed-name>
                                    <ce:surname>Widschwendter</ce:surname>
                                </author>
                                <author seq="2">
                                    <ce:initials>K.D.</ce:initials>
                                    <ce:indexed-name>Siegmund K.D.</ce:indexed-name>
                                    <ce:surname>Siegmund</ce:surname>
                                </author>
                                <author seq="3">
                                    <ce:initials>H.M.</ce:initials>
                                    <ce:indexed-name>Muller H.M.</ce:indexed-name>
                                    <ce:surname>Müller</ce:surname>
                                </author>
                                <author seq="4">
                                    <ce:initials>H.</ce:initials>
                                    <ce:indexed-name>Fiegl H.</ce:indexed-name>
                                    <ce:surname>Fiegl</ce:surname>
                                </author>
                                <author seq="5">
                                    <ce:initials>C.</ce:initials>
                                    <ce:indexed-name>Marth C.</ce:indexed-name>
                                    <ce:surname>Marth</ce:surname>
                                </author>
                                <author seq="6">
                                    <ce:initials>E.</ce:initials>
                                    <ce:indexed-name>Muller-Holzner E.</ce:indexed-name>
                                    <ce:surname>Müller-Holzner</ce:surname>
                                </author>
                                <author seq="7">
                                    <ce:initials>P.A.</ce:initials>
                                    <ce:indexed-name>Jones P.A.</ce:indexed-name>
                                    <ce:surname>Jones</ce:surname>
                                </author>
                                <author seq="8">
                                    <ce:initials>P.W.</ce:initials>
                                    <ce:indexed-name>Laird P.W.</ce:indexed-name>
                                    <ce:surname>Laird</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>Cancer Res</ref-sourcetitle>
                            <ref-publicationyear first="2004"/>
                            <ref-volisspag>
                                <voliss volume="64"/>
                                <pagerange first="3807" last="3813"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>Widschwendter M, Siegmund KD, Müller HM, Fiegl H, Marth C, Müller-Holzner E, Jones PA, Laird PW (2004) Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res 64:3807-3813</ref-fulltext>
                    </reference>
                    <reference id="9">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">0027235762</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>G.</ce:initials>
                                    <ce:indexed-name>Gasparini G.</ce:indexed-name>
                                    <ce:surname>Gasparini</ce:surname>
                                </author>
                                <author seq="2">
                                    <ce:initials>F.</ce:initials>
                                    <ce:indexed-name>Pozza F.</ce:indexed-name>
                                    <ce:surname>Pozza</ce:surname>
                                </author>
                                <author seq="3">
                                    <ce:initials>A.L.</ce:initials>
                                    <ce:indexed-name>Harris A.L.</ce:indexed-name>
                                    <ce:surname>Harris</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>J Natl Cancer Inst</ref-sourcetitle>
                            <ref-publicationyear first="1993"/>
                            <ref-volisspag>
                                <voliss volume="85"/>
                                <pagerange first="1206" last="1219"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>Gasparini G, Pozza F, Harris AL (1993) Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J Natl Cancer Inst 85:1206-1219</ref-fulltext>
                    </reference>
                    <reference id="10">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>The oncoprotein 18/stathmin family of microtubule destabilizers</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">0036468982</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>L.</ce:initials>
                                    <ce:indexed-name>Cassimeris L.</ce:indexed-name>
                                    <ce:surname>Cassimeris</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>Curr Opin Cell Biol</ref-sourcetitle>
                            <ref-publicationyear first="2002"/>
                            <ref-volisspag>
                                <voliss volume="14"/>
                                <pagerange first="18" last="24"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>Cassimeris L (2002) The oncoprotein 18/stathmin family of microtubule destabilizers. Curr Opin Cell Biol 14:18-24</ref-fulltext>
                    </reference>
                    <reference id="11">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>The S100 family of EF-hand calcium-binding proteins: Functions and pathology</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">0029669991</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>B.W.</ce:initials>
                                    <ce:indexed-name>Schafer B.W.</ce:indexed-name>
                                    <ce:surname>Schafer</ce:surname>
                                </author>
                                <author seq="2">
                                    <ce:initials>C.W.</ce:initials>
                                    <ce:indexed-name>Heizmann C.W.</ce:indexed-name>
                                    <ce:surname>Heizmann</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>Trend Biochem Sci</ref-sourcetitle>
                            <ref-publicationyear first="1996"/>
                            <ref-volisspag>
                                <voliss volume="21"/>
                                <pagerange first="134" last="140"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>Schafer BW, Heizmann CW (1996) The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trend Biochem Sci 21:134-140</ref-fulltext>
                    </reference>
                    <reference id="12">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">0034680108</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>P.J.</ce:initials>
                                    <ce:indexed-name>Coopman P.J.</ce:indexed-name>
                                    <ce:surname>Coopman</ce:surname>
                                </author>
                                <author seq="2">
                                    <ce:initials>M.T.</ce:initials>
                                    <ce:indexed-name>Do M.T.</ce:indexed-name>
                                    <ce:surname>Do</ce:surname>
                                </author>
                                <author seq="3">
                                    <ce:initials>M.</ce:initials>
                                    <ce:indexed-name>Barth M.</ce:indexed-name>
                                    <ce:surname>Barth</ce:surname>
                                </author>
                                <author seq="4">
                                    <ce:initials>E.T.</ce:initials>
                                    <ce:indexed-name>Bowden E.T.</ce:indexed-name>
                                    <ce:surname>Bowden</ce:surname>
                                </author>
                                <author seq="5">
                                    <ce:initials>A.J.</ce:initials>
                                    <ce:indexed-name>Hayes A.J.</ce:indexed-name>
                                    <ce:surname>Hayes</ce:surname>
                                </author>
                                <author seq="6">
                                    <ce:initials>E.</ce:initials>
                                    <ce:indexed-name>Basyuk E.</ce:indexed-name>
                                    <ce:surname>Basyuk</ce:surname>
                                </author>
                                <author seq="7">
                                    <ce:initials>J.K.</ce:initials>
                                    <ce:indexed-name>Blancato J.K.</ce:indexed-name>
                                    <ce:surname>Blancato</ce:surname>
                                </author>
                                <author seq="8">
                                    <ce:initials>P.R.</ce:initials>
                                    <ce:indexed-name>Vezza P.R.</ce:indexed-name>
                                    <ce:surname>Vezza</ce:surname>
                                </author>
                                <author seq="9">
                                    <ce:initials>S.W.</ce:initials>
                                    <ce:indexed-name>McLeskey S.W.</ce:indexed-name>
                                    <ce:surname>McLeskey</ce:surname>
                                </author>
                                <author seq="10">
                                    <ce:initials>P.H.</ce:initials>
                                    <ce:indexed-name>Mangeat P.H.</ce:indexed-name>
                                    <ce:surname>Mangeat</ce:surname>
                                </author>
                                <author seq="11">
                                    <ce:initials>S.C.</ce:initials>
                                    <ce:indexed-name>Mueller S.C.</ce:indexed-name>
                                    <ce:surname>Mueller</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>Nature</ref-sourcetitle>
                            <ref-publicationyear first="2000"/>
                            <ref-volisspag>
                                <voliss volume="406"/>
                                <pagerange first="742" last="747"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>Coopman PJ, Do MT, Barth M, Bowden ET, hayes AJ, Basyuk E, Blancato JK, Vezza PR, McLeskey SW, Mangeat PH, Mueller SC (2000) The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 406:742-747</ref-fulltext>
                    </reference>
                    <reference id="13">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>Reporting recommendations for tumor marker prognostic studies (REMARK)</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">26944496117</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>L.M.</ce:initials>
                                    <ce:indexed-name>McShane L.M.</ce:indexed-name>
                                    <ce:surname>McShane</ce:surname>
                                </author>
                                <author seq="2">
                                    <ce:initials>D.G.</ce:initials>
                                    <ce:indexed-name>Altman D.G.</ce:indexed-name>
                                    <ce:surname>Altman</ce:surname>
                                </author>
                                <author seq="3">
                                    <ce:initials>W.</ce:initials>
                                    <ce:indexed-name>Sauerbrei W.</ce:indexed-name>
                                    <ce:surname>Sauerbrei</ce:surname>
                                </author>
                                <author seq="4">
                                    <ce:initials>S.E.</ce:initials>
                                    <ce:indexed-name>Taube S.E.</ce:indexed-name>
                                    <ce:surname>Taube</ce:surname>
                                </author>
                                <author seq="5">
                                    <ce:initials>M.</ce:initials>
                                    <ce:indexed-name>Gion M.</ce:indexed-name>
                                    <ce:surname>Gion</ce:surname>
                                </author>
                                <author seq="6">
                                    <ce:initials>G.M.</ce:initials>
                                    <ce:indexed-name>Clark G.M.</ce:indexed-name>
                                    <ce:surname>Clark</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>Nat Clin Pract Oncol</ref-sourcetitle>
                            <ref-publicationyear first="2005"/>
                            <ref-volisspag>
                                <voliss volume="2"/>
                                <pagerange first="416" last="422"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) Reporting recommendations for tumor marker prognostic studies (REMARK). Nat Clin Pract Oncol 2:416-422</ref-fulltext>
                    </reference>
                    <reference id="14">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>Pathological prognostic factors in breast cancer. I. the value of histological grade in breast cancer: Experience from a large study with long-term follow-up</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">0026072872</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>C.W.</ce:initials>
                                    <ce:indexed-name>Elston C.W.</ce:indexed-name>
                                    <ce:surname>Elston</ce:surname>
                                </author>
                                <author seq="2">
                                    <ce:initials>I.O.</ce:initials>
                                    <ce:indexed-name>Ellis I.O.</ce:indexed-name>
                                    <ce:surname>Ellis</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>Histopathology</ref-sourcetitle>
                            <ref-publicationyear first="1991"/>
                            <ref-volisspag>
                                <voliss volume="19"/>
                                <pagerange first="403" last="410"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403-410</ref-fulltext>
                    </reference>
                    <reference id="15">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>Molecular portraits of human breast tumours</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">0034680102</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>C.M.</ce:initials>
                                    <ce:indexed-name>Perou C.M.</ce:indexed-name>
                                    <ce:surname>Perou</ce:surname>
                                </author>
                                <author seq="2">
                                    <ce:initials>T.</ce:initials>
                                    <ce:indexed-name>Sorlie T.</ce:indexed-name>
                                    <ce:surname>Sorlie</ce:surname>
                                </author>
                                <author seq="3">
                                    <ce:initials>M.B.</ce:initials>
                                    <ce:indexed-name>Eisen M.B.</ce:indexed-name>
                                    <ce:surname>Eisen</ce:surname>
                                </author>
                                <author seq="4">
                                    <ce:initials>M.</ce:initials>
                                    <ce:indexed-name>Van De Rijn M.</ce:indexed-name>
                                    <ce:surname>Van De Rijn</ce:surname>
                                </author>
                                <author seq="5">
                                    <ce:initials>S.S.</ce:initials>
                                    <ce:indexed-name>Jeffrey S.S.</ce:indexed-name>
                                    <ce:surname>Jeffrey</ce:surname>
                                </author>
                                <author seq="6">
                                    <ce:initials>C.A.</ce:initials>
                                    <ce:indexed-name>Rees C.A.</ce:indexed-name>
                                    <ce:surname>Rees</ce:surname>
                                </author>
                                <author seq="7">
                                    <ce:initials>J.R.</ce:initials>
                                    <ce:indexed-name>Pollack J.R.</ce:indexed-name>
                                    <ce:surname>Pollack</ce:surname>
                                </author>
                                <author seq="8">
                                    <ce:initials>D.T.</ce:initials>
                                    <ce:indexed-name>Ross D.T.</ce:indexed-name>
                                    <ce:surname>Ross</ce:surname>
                                </author>
                                <author seq="9">
                                    <ce:initials>H.</ce:initials>
                                    <ce:indexed-name>Johnsen H.</ce:indexed-name>
                                    <ce:surname>Johnsen</ce:surname>
                                </author>
                                <author seq="10">
                                    <ce:initials>L.A.</ce:initials>
                                    <ce:indexed-name>Akslen L.A.</ce:indexed-name>
                                    <ce:surname>Akslen</ce:surname>
                                </author>
                                <author seq="11">
                                    <ce:initials>O.</ce:initials>
                                    <ce:indexed-name>Fluge O.</ce:indexed-name>
                                    <ce:surname>Fluge</ce:surname>
                                </author>
                                <author seq="12">
                                    <ce:initials>A.</ce:initials>
                                    <ce:indexed-name>Pergamenschikov A.</ce:indexed-name>
                                    <ce:surname>Pergamenschikov</ce:surname>
                                </author>
                                <author seq="13">
                                    <ce:initials>C.</ce:initials>
                                    <ce:indexed-name>Williams C.</ce:indexed-name>
                                    <ce:surname>Williams</ce:surname>
                                </author>
                                <author seq="14">
                                    <ce:initials>S.X.</ce:initials>
                                    <ce:indexed-name>Zhu S.X.</ce:indexed-name>
                                    <ce:surname>Zhu</ce:surname>
                                </author>
                                <author seq="15">
                                    <ce:initials>P.E.</ce:initials>
                                    <ce:indexed-name>Lonning P.E.</ce:indexed-name>
                                    <ce:surname>Lonning</ce:surname>
                                </author>
                                <author seq="16">
                                    <ce:initials>A.L.</ce:initials>
                                    <ce:indexed-name>Borresen-Dale A.L.</ce:indexed-name>
                                    <ce:surname>Borresen-Dale</ce:surname>
                                </author>
                                <author seq="17">
                                    <ce:initials>P.O.</ce:initials>
                                    <ce:indexed-name>Brown P.O.</ce:indexed-name>
                                    <ce:surname>Brown</ce:surname>
                                </author>
                                <author seq="18">
                                    <ce:initials>D.</ce:initials>
                                    <ce:indexed-name>Botstein D.</ce:indexed-name>
                                    <ce:surname>Botstein</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>Nature</ref-sourcetitle>
                            <ref-publicationyear first="2000"/>
                            <ref-volisspag>
                                <voliss volume="406"/>
                                <pagerange first="747" last="752"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406:747-752</ref-fulltext>
                    </reference>
                    <reference id="16">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>Hypermethylation leads to silencing of the SYK gene in human breast cancer</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">0035879017</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>Y.</ce:initials>
                                    <ce:indexed-name>Yuan Y.</ce:indexed-name>
                                    <ce:surname>Yuan</ce:surname>
                                </author>
                                <author seq="2">
                                    <ce:initials>R.</ce:initials>
                                    <ce:indexed-name>Mendez R.</ce:indexed-name>
                                    <ce:surname>Mendez</ce:surname>
                                </author>
                                <author seq="3">
                                    <ce:initials>A.</ce:initials>
                                    <ce:indexed-name>Sahin A.</ce:indexed-name>
                                    <ce:surname>Sahin</ce:surname>
                                </author>
                                <author seq="4">
                                    <ce:initials>J.L.</ce:initials>
                                    <ce:indexed-name>Dai J.L.</ce:indexed-name>
                                    <ce:surname>Dai</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>Cancer Res</ref-sourcetitle>
                            <ref-publicationyear first="2001"/>
                            <ref-volisspag>
                                <voliss volume="61"/>
                                <pagerange first="5558" last="5561"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>Yuan Y, Mendez R, Sahin A, Dai JL (2001) Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res 61:5558-5561</ref-fulltext>
                    </reference>
                    <reference id="17">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">0037427571</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>T.</ce:initials>
                                    <ce:indexed-name>Toyama T.</ce:indexed-name>
                                    <ce:surname>Toyama</ce:surname>
                                </author>
                                <author seq="2">
                                    <ce:initials>H.</ce:initials>
                                    <ce:indexed-name>Iwase H.</ce:indexed-name>
                                    <ce:surname>Iwase</ce:surname>
                                </author>
                                <author seq="3">
                                    <ce:initials>H.</ce:initials>
                                    <ce:indexed-name>Yamashita H.</ce:indexed-name>
                                    <ce:surname>Yamashita</ce:surname>
                                </author>
                                <author seq="4">
                                    <ce:initials>Y.</ce:initials>
                                    <ce:indexed-name>Hara Y.</ce:indexed-name>
                                    <ce:surname>Hara</ce:surname>
                                </author>
                                <author seq="5">
                                    <ce:initials>H.</ce:initials>
                                    <ce:indexed-name>Omoto Yamashita H.</ce:indexed-name>
                                    <ce:surname>Omoto Yamashita</ce:surname>
                                </author>
                                <author seq="6">
                                    <ce:initials>Y.</ce:initials>
                                    <ce:indexed-name>Hara Y.</ce:indexed-name>
                                    <ce:surname>Hara</ce:surname>
                                </author>
                                <author seq="7">
                                    <ce:initials>Y.</ce:initials>
                                    <ce:indexed-name>Omoto Y.</ce:indexed-name>
                                    <ce:surname>Omoto</ce:surname>
                                </author>
                                <author seq="8">
                                    <ce:initials>H.</ce:initials>
                                    <ce:indexed-name>Suigura H.</ce:indexed-name>
                                    <ce:surname>Suigura</ce:surname>
                                </author>
                                <author seq="9">
                                    <ce:initials>Z.</ce:initials>
                                    <ce:indexed-name>Zhang Z.</ce:indexed-name>
                                    <ce:surname>Zhang</ce:surname>
                                </author>
                                <author seq="10">
                                    <ce:initials>Y.</ce:initials>
                                    <ce:indexed-name>Fujii Y.</ce:indexed-name>
                                    <ce:surname>Fujii</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>2003 Cancer Lett</ref-sourcetitle>
                            <ref-publicationyear first="2003"/>
                            <ref-volisspag>
                                <voliss volume="189"/>
                                <pagerange first="97" last="102"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>Toyama T, Iwase H, Yamashita H, Hara Y, Omoto Yamashita H, Hara Y, Omoto Y, Suigura H, Zhang Z, Fujii Y (2003) Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer. 2003 Cancer Lett.189:97-102</ref-fulltext>
                    </reference>
                    <reference id="18">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">0030048731</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>L.D.</ce:initials>
                                    <ce:indexed-name>Belmont L.D.</ce:indexed-name>
                                    <ce:surname>Belmont</ce:surname>
                                </author>
                                <author seq="2">
                                    <ce:initials>T.J.</ce:initials>
                                    <ce:indexed-name>Mitchison T.J.</ce:indexed-name>
                                    <ce:surname>Mitchison</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>Cell</ref-sourcetitle>
                            <ref-publicationyear first="1996"/>
                            <ref-volisspag>
                                <voliss volume="84"/>
                                <pagerange first="623" last="631"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>Belmont LD, Mitchison TJ (1996) Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. Cell 84:623-631</ref-fulltext>
                    </reference>
                    <reference id="19">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">0033989769</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>C.</ce:initials>
                                    <ce:indexed-name>Curmi C.</ce:indexed-name>
                                    <ce:surname>Curmi</ce:surname>
                                </author>
                                <author seq="2">
                                    <ce:initials>P.A.</ce:initials>
                                    <ce:indexed-name>Curmi P.A.</ce:indexed-name>
                                    <ce:surname>Curmi</ce:surname>
                                </author>
                                <author seq="3">
                                    <ce:initials>C.</ce:initials>
                                    <ce:indexed-name>Nogues C.</ce:indexed-name>
                                    <ce:surname>Nogues</ce:surname>
                                </author>
                                <author seq="4">
                                    <ce:initials>S.</ce:initials>
                                    <ce:indexed-name>Lackhar S.</ce:indexed-name>
                                    <ce:surname>Lackhar</ce:surname>
                                </author>
                                <author seq="5">
                                    <ce:initials>N.</ce:initials>
                                    <ce:indexed-name>Carelle N.</ce:indexed-name>
                                    <ce:surname>Carelle</ce:surname>
                                </author>
                                <author seq="6">
                                    <ce:initials>M.P.</ce:initials>
                                    <ce:indexed-name>Gopnthier M.P.</ce:indexed-name>
                                    <ce:surname>Gopnthier</ce:surname>
                                </author>
                                <author seq="7">
                                    <ce:initials>A.</ce:initials>
                                    <ce:indexed-name>Sobel A.</ce:indexed-name>
                                    <ce:surname>Sobel</ce:surname>
                                </author>
                                <author seq="8">
                                    <ce:initials>R.</ce:initials>
                                    <ce:indexed-name>Lidereau R.</ce:indexed-name>
                                    <ce:surname>Lidereau</ce:surname>
                                </author>
                                <author seq="9">
                                    <ce:initials>I.</ce:initials>
                                    <ce:indexed-name>Bieche I.</ce:indexed-name>
                                    <ce:surname>Bieche</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>Br J Cancer</ref-sourcetitle>
                            <ref-publicationyear first="2000"/>
                            <ref-volisspag>
                                <voliss volume="82"/>
                                <pagerange first="142" last="150"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>Curmi C, Curmi PA, Nogues C, Lackhar S, Carelle N, Gopnthier MP, Sobel A, Lidereau R, Bieche I (2000) Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours. Br J Cancer 82:142-150</ref-fulltext>
                    </reference>
                    <reference id="20">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">0033947942</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>G.</ce:initials>
                                    <ce:indexed-name>Brattsand G.</ce:indexed-name>
                                    <ce:surname>Brattsand</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>Br J Cancer</ref-sourcetitle>
                            <ref-publicationyear first="2000"/>
                            <ref-volisspag>
                                <voliss volume="83"/>
                                <pagerange first="311" last="318"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>Brattsand G (2000) Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors. Br J Cancer 83:311-318</ref-fulltext>
                    </reference>
                    <reference id="21">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">19944422061</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>S.</ce:initials>
                                    <ce:indexed-name>Paik S.</ce:indexed-name>
                                    <ce:surname>Paik</ce:surname>
                                </author>
                                <author seq="2">
                                    <ce:initials>S.</ce:initials>
                                    <ce:indexed-name>Shak S.</ce:indexed-name>
                                    <ce:surname>Shak</ce:surname>
                                </author>
                                <author seq="3">
                                    <ce:initials>G.</ce:initials>
                                    <ce:indexed-name>Tang G.</ce:indexed-name>
                                    <ce:surname>Tang</ce:surname>
                                </author>
                                <author seq="4">
                                    <ce:initials>C.</ce:initials>
                                    <ce:indexed-name>Kim C.</ce:indexed-name>
                                    <ce:surname>Kim</ce:surname>
                                </author>
                                <author seq="5">
                                    <ce:initials>J.</ce:initials>
                                    <ce:indexed-name>Baker J.</ce:indexed-name>
                                    <ce:surname>Baker</ce:surname>
                                </author>
                                <author seq="6">
                                    <ce:initials>M.</ce:initials>
                                    <ce:indexed-name>Cronin M.</ce:indexed-name>
                                    <ce:surname>Cronin</ce:surname>
                                </author>
                                <author seq="7">
                                    <ce:initials>F.L.</ce:initials>
                                    <ce:indexed-name>Baehner F.L.</ce:indexed-name>
                                    <ce:surname>Baehner</ce:surname>
                                </author>
                                <author seq="8">
                                    <ce:initials>M.G.</ce:initials>
                                    <ce:indexed-name>Walker M.G.</ce:indexed-name>
                                    <ce:surname>Walker</ce:surname>
                                </author>
                                <author seq="9">
                                    <ce:initials>D.</ce:initials>
                                    <ce:indexed-name>Watson D.</ce:indexed-name>
                                    <ce:surname>Watson</ce:surname>
                                </author>
                                <author seq="10">
                                    <ce:initials>T.</ce:initials>
                                    <ce:indexed-name>Park T.</ce:indexed-name>
                                    <ce:surname>Park</ce:surname>
                                </author>
                                <author seq="11">
                                    <ce:initials>W.</ce:initials>
                                    <ce:indexed-name>Hiller W.</ce:indexed-name>
                                    <ce:surname>Hiller</ce:surname>
                                </author>
                                <author seq="12">
                                    <ce:initials>E.R.</ce:initials>
                                    <ce:indexed-name>Fisher E.R.</ce:indexed-name>
                                    <ce:surname>Fisher</ce:surname>
                                </author>
                                <author seq="13">
                                    <ce:initials>D.L.</ce:initials>
                                    <ce:indexed-name>Wickerham D.L.</ce:indexed-name>
                                    <ce:surname>Wickerham</ce:surname>
                                </author>
                                <author seq="14">
                                    <ce:initials>J.</ce:initials>
                                    <ce:indexed-name>Bryant J.</ce:indexed-name>
                                    <ce:surname>Bryant</ce:surname>
                                </author>
                                <author seq="15">
                                    <ce:initials>N.</ce:initials>
                                    <ce:indexed-name>Wolmark N.</ce:indexed-name>
                                    <ce:surname>Wolmark</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>N Engl J Med</ref-sourcetitle>
                            <ref-publicationyear first="2004"/>
                            <ref-volisspag>
                                <voliss volume="351"/>
                                <pagerange first="2817" last="2826"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351:2817-2826</ref-fulltext>
                    </reference>
                    <reference id="22">
                        <ref-info>
                            <ref-title>
                                <ref-titletext>A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen</ref-titletext>
                            </ref-title>
                            <refd-itemidlist>
                                <itemid idtype="SGR">2942578063</itemid>
                            </refd-itemidlist>
                            <ref-authors>
                                <author seq="1">
                                    <ce:initials>X.J.</ce:initials>
                                    <ce:indexed-name>Ma X.J.</ce:indexed-name>
                                    <ce:surname>Ma</ce:surname>
                                </author>
                                <author seq="2">
                                    <ce:initials>Z.</ce:initials>
                                    <ce:indexed-name>Wang Z.</ce:indexed-name>
                                    <ce:surname>Wang</ce:surname>
                                </author>
                                <author seq="3">
                                    <ce:initials>P.D.</ce:initials>
                                    <ce:indexed-name>Ryan P.D.</ce:indexed-name>
                                    <ce:surname>Ryan</ce:surname>
                                </author>
                                <author seq="4">
                                    <ce:initials>S.J.</ce:initials>
                                    <ce:indexed-name>Isakoff S.J.</ce:indexed-name>
                                    <ce:surname>Isakoff</ce:surname>
                                </author>
                                <author seq="5">
                                    <ce:initials>A.</ce:initials>
                                    <ce:indexed-name>Barmettler A.</ce:indexed-name>
                                    <ce:surname>Barmettler</ce:surname>
                                </author>
                                <author seq="6">
                                    <ce:initials>A.</ce:initials>
                                    <ce:indexed-name>Fuller A.</ce:indexed-name>
                                    <ce:surname>Fuller</ce:surname>
                                </author>
                                <author seq="7">
                                    <ce:initials>B.</ce:initials>
                                    <ce:indexed-name>Muir B.</ce:indexed-name>
                                    <ce:surname>Muir</ce:surname>
                                </author>
                                <author seq="8">
                                    <ce:initials>G.</ce:initials>
                                    <ce:indexed-name>Mohapatra G.</ce:indexed-name>
                                    <ce:surname>Mohapatra</ce:surname>
                                </author>
                                <author seq="9">
                                    <ce:initials>R.</ce:initials>
                                    <ce:indexed-name>Salunga R.</ce:indexed-name>
                                    <ce:surname>Salunga</ce:surname>
                                </author>
                                <author seq="10">
                                    <ce:initials>J.T.</ce:initials>
                                    <ce:indexed-name>Tuggle J.T.</ce:indexed-name>
                                    <ce:surname>Tuggle</ce:surname>
                                </author>
                                <author seq="11">
                                    <ce:initials>Y.</ce:initials>
                                    <ce:indexed-name>Tran Y.</ce:indexed-name>
                                    <ce:surname>Tran</ce:surname>
                                </author>
                                <author seq="12">
                                    <ce:initials>D.</ce:initials>
                                    <ce:indexed-name>Tran D.</ce:indexed-name>
                                    <ce:surname>Tran</ce:surname>
                                </author>
                                <author seq="13">
                                    <ce:initials>A.</ce:initials>
                                    <ce:indexed-name>Tassin A.</ce:indexed-name>
                                    <ce:surname>Tassin</ce:surname>
                                </author>
                                <author seq="14">
                                    <ce:initials>P.</ce:initials>
                                    <ce:indexed-name>Amon P.</ce:indexed-name>
                                    <ce:surname>Amon</ce:surname>
                                </author>
                                <author seq="15">
                                    <ce:initials>W.</ce:initials>
                                    <ce:indexed-name>Wang W.</ce:indexed-name>
                                    <ce:surname>Wang</ce:surname>
                                </author>
                                <author seq="16">
                                    <ce:initials>W.</ce:initials>
                                    <ce:indexed-name>Wang W.</ce:indexed-name>
                                    <ce:surname>Wang</ce:surname>
                                </author>
                                <author seq="17">
                                    <ce:initials>E.</ce:initials>
                                    <ce:indexed-name>Enright E.</ce:indexed-name>
                                    <ce:surname>Enright</ce:surname>
                                </author>
                                <author seq="18">
                                    <ce:initials>K.</ce:initials>
                                    <ce:indexed-name>Stecker K.</ce:indexed-name>
                                    <ce:surname>Stecker</ce:surname>
                                </author>
                                <author seq="19">
                                    <ce:initials>E.</ce:initials>
                                    <ce:indexed-name>Estepa-Sabal E.</ce:indexed-name>
                                    <ce:surname>Estepa-Sabal</ce:surname>
                                </author>
                                <author seq="20">
                                    <ce:initials>B.</ce:initials>
                                    <ce:indexed-name>Smith B.</ce:indexed-name>
                                    <ce:surname>Smith</ce:surname>
                                </author>
                                <author seq="21">
                                    <ce:initials>J.</ce:initials>
                                    <ce:indexed-name>Younger J.</ce:indexed-name>
                                    <ce:surname>Younger</ce:surname>
                                </author>
                                <author seq="22">
                                    <ce:initials>U.</ce:initials>
                                    <ce:indexed-name>Balis U.</ce:indexed-name>
                                    <ce:surname>Balis</ce:surname>
                                </author>
                                <author seq="23">
                                    <ce:initials>J.</ce:initials>
                                    <ce:indexed-name>Michaelson J.</ce:indexed-name>
                                    <ce:surname>Michaelson</ce:surname>
                                </author>
                                <author seq="24">
                                    <ce:initials>A.</ce:initials>
                                    <ce:indexed-name>Bhan A.</ce:indexed-name>
                                    <ce:surname>Bhan</ce:surname>
                                </author>
                                <author seq="25">
                                    <ce:initials>K.</ce:initials>
                                    <ce:indexed-name>Habin K.</ce:indexed-name>
                                    <ce:surname>Habin</ce:surname>
                                </author>
                                <author seq="26">
                                    <ce:initials>T.M.</ce:initials>
                                    <ce:indexed-name>Baer T.M.</ce:indexed-name>
                                    <ce:surname>Baer</ce:surname>
                                </author>
                                <author seq="27">
                                    <ce:initials>J.</ce:initials>
                                    <ce:indexed-name>Brugge J.</ce:indexed-name>
                                    <ce:surname>Brugge</ce:surname>
                                </author>
                                <author seq="28">
                                    <ce:initials>D.A.</ce:initials>
                                    <ce:indexed-name>Haber D.A.</ce:indexed-name>
                                    <ce:surname>Haber</ce:surname>
                                </author>
                                <author seq="29">
                                    <ce:initials>M.G.</ce:initials>
                                    <ce:indexed-name>Erlander M.G.</ce:indexed-name>
                                    <ce:surname>Erlander</ce:surname>
                                </author>
                                <author seq="30">
                                    <ce:initials>D.C.</ce:initials>
                                    <ce:indexed-name>Sgroi D.C.</ce:indexed-name>
                                    <ce:surname>Sgroi</ce:surname>
                                </author>
                            </ref-authors>
                            <ref-sourcetitle>Cancer Cell</ref-sourcetitle>
                            <ref-publicationyear first="2004"/>
                            <ref-volisspag>
                                <voliss volume="5"/>
                                <pagerange first="607" last="616"/>
                            </ref-volisspag>
                        </ref-info>
                        <ref-fulltext>Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A, Muir B, Mohapatra G, Salunga R, Tuggle JT, Tran Y, Tran D, Tassin A, Amon P, Wang W, Wang W, Enright E, Stecker K, Estepa-Sabal E, Smith B, Younger J, Balis U, Michaelson J, Bhan A, Habin K, Baer TM, Brugge J, Haber DA, Erlander MG, Sgroi DC (2004) A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 5:607-616</ref-fulltext>
                    </reference>
                </bibliography></tail></bibrecord></item></abstracts-retrieval-response>